176 related articles for article (PubMed ID: 16868129)
1. Nanotechnology and the occupational physician.
Seaton A
Occup Med (Lond); 2006 Aug; 56(5):312-6. PubMed ID: 16868129
[TBL] [Abstract][Full Text] [Related]
2. Exposure to manufactured nanoparticles in different workplaces.
Brouwer D
Toxicology; 2010 Mar; 269(2-3):120-7. PubMed ID: 19941928
[TBL] [Abstract][Full Text] [Related]
3. Nanocommentary: Occupational and environmental health and nanotechnology--what's new?
Sng J; Koh D
Occup Med (Lond); 2008 Oct; 58(7):454-5. PubMed ID: 18845554
[No Abstract] [Full Text] [Related]
4. Nanotechnology safety concerns revisited.
Stern ST; McNeil SE
Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
[TBL] [Abstract][Full Text] [Related]
5. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
Warheit DB; Sayes CM; Reed KL; Swain KA
Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles: a review of particle toxicology following inhalation exposure.
Bakand S; Hayes A; Dechsakulthorn F
Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
[TBL] [Abstract][Full Text] [Related]
7. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
8. [Nanoparticles (part 1)--the product of modern technology and new hazards in the work environment].
Swidwińska-Gajewska AM
Med Pr; 2007; 58(3):243-51. PubMed ID: 17926515
[TBL] [Abstract][Full Text] [Related]
9. [Occupational exposure to nanoparticles. Assessment of workplace exposure].
Bujak-Pietrek S
Med Pr; 2010; 61(2):183-9. PubMed ID: 20509555
[TBL] [Abstract][Full Text] [Related]
10. [Problem of safety provision of nanodimensional objects for human health].
Khotimchenko SA; Gmoshinskiĭ IV; Tutel'ian VA
Gig Sanit; 2009; (5):7-11. PubMed ID: 20050058
[TBL] [Abstract][Full Text] [Related]
11. The Janus faces of nanoparticles.
Donaldson K; Seaton A
J Nanosci Nanotechnol; 2007 Dec; 7(12):4607-11. PubMed ID: 18283852
[TBL] [Abstract][Full Text] [Related]
12. [The occupational medicine physician and risk evaluation: between technical arguments and regulative obligations].
Apostoli P
G Ital Med Lav; 1996; 18(4-6):121-8. PubMed ID: 9410783
[TBL] [Abstract][Full Text] [Related]
13. [Nanotechnology--possibilities and hazards].
Snopczyński T; Góralczyk K; Czaja K; Struciński P; Hernik A; Korcz W; Ludwicki JK
Rocz Panstw Zakl Hig; 2009; 60(2):101-11. PubMed ID: 19803438
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment.
Bergamaschi E; Bussolati O; Magrini A; Bottini M; Migliore L; Bellucci S; Iavicoli I; Bergamaschi A
Int J Immunopathol Pharmacol; 2006; 19(4 Suppl):3-10. PubMed ID: 17291399
[TBL] [Abstract][Full Text] [Related]
15. Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials.
Trout DB; Schulte PA
Toxicology; 2010 Mar; 269(2-3):128-35. PubMed ID: 20006668
[TBL] [Abstract][Full Text] [Related]
16. [Fine, ultrafine and nano- particles in the living and working setting: potential health effects and measurement of inhalation exposure].
Marconi A
G Ital Med Lav Ergon; 2006; 28(3):258-65. PubMed ID: 17144413
[TBL] [Abstract][Full Text] [Related]
17. Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials.
Franco A; Hansen SF; Olsen SI; Butti L
Regul Toxicol Pharmacol; 2007 Jul; 48(2):171-83. PubMed ID: 17509740
[TBL] [Abstract][Full Text] [Related]
18. [Principles of air sampling and interpretation of its results in evaluating occupational exposure to toxic substances in the work area. II. Stationary measurements].
Gromiec JP; Rogaczewska T
Med Pr; 1989; 40(5):302-9. PubMed ID: 2628698
[TBL] [Abstract][Full Text] [Related]
19. Occupational exposure to antimony compounds.
McCallum RI
J Environ Monit; 2005 Dec; 7(12):1245-50. PubMed ID: 16307078
[TBL] [Abstract][Full Text] [Related]
20. European and international standardisation progress in the field of engineered nanoparticles.
Rivière G
Inhal Toxicol; 2009 Jul; 21 Suppl 1():2-7. PubMed ID: 19558227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
